Lyme Disease Testing Practices, Wisconsin, USA, 2016-2019
- PMID: 40562745
- PMCID: PMC12205465
- DOI: 10.3201/eid3107.250009
Lyme Disease Testing Practices, Wisconsin, USA, 2016-2019
Abstract
Positive laboratory results are increasingly used for Lyme disease surveillance in the United States. We found 6%-15% of persons with a positive test each year tested positive in a prior year; repeat testing frequency increased with patient age. Repeat testing of persons with previous seropositivity could affect surveillance data interpretation.
Keywords: Borrelia burgdorferi; Lyme disease; United States; Wisconsin; bacteria; laboratory testing; surveillance; vector-borne infections; zoonoses.
Figures
References
-
- Steere A. Lyme disease (Lyme borreliosis) due to Borrelia burgdorferi. In: Bennett JE, Dolin R, Blaser M, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Philadelphia: Elsevier; 2020. p. 2911–22.
-
- Centers for Disease Control and Prevention. Lyme disease surveillance data [cited 2024 Jul 25]. https://www.cdc.gov/lyme/data-research/facts-stats/surveillance-data-1.html
-
- Centers for Disease Control and Prevention (CDC). Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep. 1995;44:590–1. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
